The programme touches upon price-sensitive announcements during early trading hours in the Australian market that would impact stock movement. Watch The Stocks in Action on Kalkine TV and stay updated.
• Shares of the ASX-listed biotechnology firm Actinogen Medical were trading up by more than 8 per cent after it announced today that it has enrolled the first patient in Part A of its two-part XanaMIA trial, which targets patients with mild Cognitive Impairment due to Alzheimer’s disease.
• Schrole Group, the global Software as a service provider to education professionals & institutions, reported today that it had released its Schrole Connect 3.0.
• Shares of Spark were trading up by more than 7 per cent, after it confirmed receiving a revised takeover bid worth $2.80 a share from a consortium led by the Ontario Teachers’ Pension Plan Board and KKR.